Published in Neurol Sci on June 15, 2010
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. Proc Natl Acad Sci U S A (2012) 0.98
Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One (2013) 0.89
Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme. Neuro Oncol (2013) 0.84
Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis. PLoS One (2014) 0.80
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects. PLoS One (2016) 0.77
Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera. Front Immunol (2017) 0.77
Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops. PLoS One (2015) 0.77
Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein. Front Immunol (2017) 0.75
Multiple sclerosis. Lancet (2002) 7.11
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol (2010) 4.95
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol (2003) 3.73
Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst (2003) 3.44
Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis (2009) 3.23
Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (1999) 3.20
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med (2007) 2.88
Seroepidemiology of the human polyomaviruses. J Gen Virol (2003) 2.32
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol (2003) 1.95
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88
Infections and autoimmune diseases. J Autoimmun (2005) 1.61
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol (2006) 1.32
Multiple sclerosis: the environment and causation. Curr Opin Neurol (2007) 1.22
BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res (1998) 1.19
Oncogenic transformation by BK virus and association with human tumors. Oncogene (2003) 1.16
Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. J Gen Virol (2001) 1.12
Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology (2004) 1.10
Simian virus 40 in humans. Infect Agent Cancer (2007) 1.09
Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis (2002) 1.07
Studies of neutralising antibodies to SV40 in human sera. J Med Virol (2003) 1.07
Infectious causes of multiple sclerosis. Lancet Neurol (2006) 1.04
Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. Br J Cancer (2005) 1.01
JC virus associated meningoencephalitis in an immunocompetent girl. Arch Dis Child (1992) 0.92
High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer (1995) 0.87
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J Natl Cancer Inst (2004) 0.82
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology (2004) 4.12
The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain (2008) 2.74
Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am J Hum Genet (2004) 2.06
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res (2005) 1.75
Risk factors of invasive cervical cancer in Mali. Int J Epidemiol (2002) 1.74
Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71
Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors. Blood (2011) 1.68
The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am J Respir Cell Mol Biol (2002) 1.53
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol (2010) 1.53
High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol (2011) 1.53
Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis (2003) 1.47
Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol (2010) 1.40
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector. Leuk Res (2013) 1.38
Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol (2013) 1.36
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol (2006) 1.32
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29
Encoding of human action in Broca's area. Brain (2009) 1.26
Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res (2003) 1.25
Cervical cancer control, priorities and new directions. Int J Cancer (2004) 1.23
Chapter 15: HPV vaccine use in the developing world. Vaccine (2006) 1.23
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature. Eur Spine J (2009) 1.23
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep (2008) 1.22
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer (2002) 1.21
miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol (2012) 1.18
Oncogenic transformation by BK virus and association with human tumors. Oncogene (2003) 1.16
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.16
Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors. Hum Immunol (2012) 1.13
A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci (2009) 1.12
Recent developments in orofacial cleft genetics. J Craniofac Surg (2003) 1.12
Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol (2002) 1.10
Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology (2004) 1.10
Simian virus 40 in humans. Infect Agent Cancer (2007) 1.09
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. FASEB J (2009) 1.09
Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol (2013) 1.06
MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol (2011) 1.06
Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg Infect Dis (2009) 1.05
Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke. Arch Phys Med Rehabil (2012) 1.02
A case of asymptomatic pontine myelinolysis. Neurol Sci (2010) 1.02
Pregnancy as a risk factor for restless legs syndrome. Sleep Med (2004) 1.01
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer (2002) 1.00
Seroprevalence and cross-reactivity of human polyomavirus 9. Emerg Infect Dis (2012) 1.00
High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. Proc Natl Acad Sci U S A (2012) 0.98
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis. Mult Scler (2006) 0.97
Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol (2013) 0.96
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J (2008) 0.96
High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol (2012) 0.95
Gait measures with a triaxial accelerometer among patients with neurological impairment. Neurol Sci (2012) 0.95
Linkage disequilibrium between GABRB3 gene and nonsyndromic familial cleft lip with or without cleft palate. Hum Genet (2001) 0.94
Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex (2005) 0.94
Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol (2008) 0.94
Hemorrhagic cystitis in children undergoing bone marrow transplantation: a putative role for simian virus 40. Transplantation (2004) 0.94
Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res (2008) 0.92
25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler (2009) 0.92
Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor. J Gen Virol (2003) 0.91
Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci (2010) 0.91
BK virus and cancer in Uganda. Eur J Cancer Prev (2006) 0.91
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions. J Clin Microbiol (2002) 0.91
Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol (2007) 0.89
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci (2007) 0.89
Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One (2013) 0.89
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol (2003) 0.89
Gender differences in health-related quality of life in multiple sclerosis. Mult Scler (2009) 0.88
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cell Biochem (2013) 0.88
Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation. J Neuroimmune Pharmacol (2013) 0.88
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol (2007) 0.88
Investigation of the W185X nonsense mutation of PVRL1 gene in Italian nonsyndromic cleft lip and palate patients. Am J Med Genet A (2004) 0.87
Seroprevalence of human Malawi polyomavirus. J Clin Microbiol (2013) 0.87
Gram-negative bacterial lipopolysaccharide retention by a positively charged new-generation filter. Appl Environ Microbiol (2008) 0.87
Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect (2008) 0.87
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Sci (2009) 0.86